Skip to main content

Peer Review reports

From: Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma

Original Submission
8 Jun 2010 Submitted Original manuscript
1 Jul 2010 Author responded Author comments - Nestor Molfino
Resubmission - Version 2
1 Jul 2010 Submitted Manuscript version 2
13 Aug 2010 Reviewed Reviewer Report - Lanny Rosenwasser
18 Aug 2010 Reviewed Reviewer Report - Dave Singh
27 Sep 2010 Author responded Author comments - Nestor Molfino
Resubmission - Version 3
27 Sep 2010 Submitted Manuscript version 3
28 Jan 2011 Author responded Author comments - Nestor Molfino
Resubmission - Version 4
28 Jan 2011 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
15 Feb 2011 Author responded Author comments - Nestor Molfino
Resubmission - Version 6
15 Feb 2011 Submitted Manuscript version 6
Publishing
28 Feb 2011 Editorially accepted
28 Feb 2011 Article published 10.1186/1471-2466-11-14

You can find further information about peer review here.

Back to article page